Get to know
TAFINLAR + MEKINIST

TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets is a treatment combination that may help those with BRAF V600E metastatic (has spread to other parts of the body) non-small cell lung cancer (NSCLC).

Important Safety Information

What is the most important information I should know about TAFINLAR in combination with MEKINIST? TAFINLAR and MEKINIST may cause serious side effects, including:

 

Risk of new skin cancers. TAFINL...

See More
Approved Use:

TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC), and that has a certain type of abnormal “BRAF V...

See More
TESTING AND DIAGNOSIS

Testing for the BRAF V600E Mutation

Your BRAF V600E mutation status could inform treatment decisions. Ask your health care provider about comprehensive testing.

Learn More about BRAF V600E
HOW TAFINLAR + MEKINIST MAY HELP

NSCLC Treatment

Discover clinical trial results in both untreated and treated people.

See proven results